Ultimovacs’ UV1 in combination with pembrolizumab shows 60% Objective Response Rate in advanced melanoma Phase I data
• UV1/pembrolizumab results in 30% complete responses plus 30% partial responses
• Good safety and tolerability profile supports use of UV1 in combination treatments
• Data to be presented at ASCO and abstract to be discussed in webcast on May...
AZTY reported sales of NOK 40.4 million (18.5) and an EBITDA of NOK 25.8 million (9.0) for the first quarter of 2021.
Highlights from Q1 2021
· ArcticZymes Technologies (AZT) had Q1 sales of NOK 40.4 million growing by 119% (Q1 2020: NOK 18.5 million)
· Coronavirus-related sales are estimated at NOK 16.5 million in Q1 2021 (NOK 3.8 million in Q1 2020)
Almost like a machine, we seem to get repeated instances of these strong drops, followed by flat trading, and then a jump back up to the start level.
I call this the reversed SEMI BART pattern, as it is not quite as flat and defined as we got used to seeing in Bitcoin, but still has some of the hallmarks of the pattern.
SOFTOX HAS COMPLETED ENROLMENT OF SOFTOX WOUND IRRIGATION SOLUTION CONFIRMATORY STUDY (SWIS-02)
SoftOx Solutions AS ("SoftOx") is pleased to announce that the enrolment of
study participants for the clinical investigation «SWIS-02» has been completed.
The study, which has been conducted at Bispebjerg University Hospital is a
confirmatory clinical investigation...
Delivery platform unicorn Glovo chooses StrongPoint as preferred supplier for grocery picking solutions
StrongPoint today announces that Glovo, the on-demand meal and grocery delivery platform available in 22 countries and one of Europe’s leading technology unicorns (a valuation of over USD 1 billion), has chosen StrongPoint as a preferred supplier for grocery...
Photocure Partners with Asieris MediTech to Commercialize Hexvix in Mainland China and Taiwan
Agreement Expands Photocure’s Hexvix®/Cysview® Franchise Footprint to over 30 Countries
Oslo, Norway January 26, 2021, Photocure ASA (PHO:OSE): The Bladder Cancer Company focused on delivering transformative solutions to improve the lives of bladder cancer patients, ...